Although CEA is a known target for therapeutic vaccination in CRC, expression of CEA may not be consistent throughout the heterogeneous tumour mass, and expression can be reduced following targeted vaccination [8, 9]. The gene discussed is CEACAM5; the disease is neoplasm.